Product Recalls in Alaska

Product recalls affecting Alaska — including food, drugs, consumer products, medical devices, and vehicles distributed to Alaska. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,550 recalls have been distributed to Alaska in the last 12 months.

46,762 total recalls
2,550 in last 12 months

Showing 20812100 of 13,360 recalls

DrugMarch 13, 2023· Direct Rx

Recalled Item: Ropinirole Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Glimepiride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Glimepiride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Ropinirole Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Finasteride Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Montelukast Sodium Tablets Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2023· Direct Rx

Recalled Item: Simvastatin Recalled by Direct Rx Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 10, 2023· Noven Pharmaceuticals Inc

Recalled Item: Daytrana (methylphenidate transdermal system) CII Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 9, 2023· Boehringer Ingelheim Pharmaceuticals, Inc.

Recalled Item: JARDIANCE (Empagliflozin) Recalled by Boehringer Ingelheim Pharmaceuticals,...

The Issue: Labeling: Label Mix-up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 9, 2023· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Dofetilide Capsules Recalled by SUN PHARMACEUTICAL INDUSTRIES INC Due to...

The Issue: Failed Content Uniformity Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 8, 2023· Pfizer Inc.

Recalled Item: MEKTOVI (binimetinib) tablets Recalled by Pfizer Inc. Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 2, 2023· Endo Pharmaceuticals, Inc.

Recalled Item: Calcitonin Salmon Nasal Spray Recalled by Endo Pharmaceuticals, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Alprazolam Tablets Recalled by Breckenridge Pharmaceutical, Inc Due to CGMP...

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Alprazolam Tablets Recalled by Breckenridge Pharmaceutical, Inc Due to CGMP...

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Alprazolam Tablets Recalled by Breckenridge Pharmaceutical, Inc Due to CGMP...

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2023· Breckenridge Pharmaceutical, Inc

Recalled Item: Alprazolam Tablets Recalled by Breckenridge Pharmaceutical, Inc Due to CGMP...

The Issue: CGMP Deviations: Potential risk of Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund